Expert Analysis

DOJ Directive Gives Contractors A Fraud Risk Road Map

For government contractors, the 10 factors described in the U.S. Department of Justice's recent corporate fraud en... (more story)

A Nuanced Reading Of DOL's Mental Health Parity Guidance

Though a recent U.S. Department of Labor bulletin may suggest that agency enforcement pressure on group health pla... (more story)

Where DOJ's Fraud Directive May Actually Affect Enforcement

The U.S. Department of Justice’s recent directive outlining corporate fraud enforcement priorities is mostly a man... (more story)

Deals & Corporate Governance More

3 Federal Circuit Clashes To Watch In November

A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are am... (more story)

​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of p... (more story)

NC Health Plan, Atrium Settle Spat Over Cost-Sharing Program

The North Carolina state health plan said on Tuesday that it will add Atrium Health to its list of in-network providers next year after a public showdown over the nonprofit health system's exclusion from the p... (more story)

Insurance Lobby Decries 'One-Two Punch' Of CMS Moratorium

Insurance brokers are in court fighting a CMS moratorium on new registrations for agents and brokers from entering Affordable Care Act exchanges. The businesses are also feeling the effects of canceled coverag... (more story)

3 Firms Steer Obesity Drugmaker Corxel's $377M SPAC Deal

Obesity-focused biopharmaceutical company Corxel Pharmaceuticals Inc. on Monday unveiled plans to go public by merging with special-purpose acquisition company Amanat Acquisition Corp. in a deal expected to ge... (more story)

In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth... (more story)

Digital Health & Technology More

Milliman Reaches $15.5M Deal In Life Insurance FCRA Suit

Risk management firm Milliman Inc. is set to pay $15.5 million to resolve a consumer class action accusing the company of peddling flawed information to life insurance companies, according to a proposed settle... (more story)

OpenAI Sued Over Epilepsy Death Allegedly Tied To ChatGPT

​The parents of a Chinese national with epilepsy who died earlier this year sued OpenAI on Tuesday in California state court, alleging ChatGPT was effectively practicing medicine without a license when it desi... (more story)

Full 9th Circ. Won't Review Surgical Robot Antitrust Fight

The full Ninth Circuit declined to reconsider an appellate panel's recent decision reviving a surgical repair company's antitrust suit alleging Intuitive Surgical blocked third parties from supplying parts for... (more story)

Intuitive Surgical Strikes $450M Deal In Robot Antitrust Suit

Intuitive Surgical said in its quarterly earnings report Tuesday that it reached a $450 million settlement to resolve a hospital class action alleging it monopolized the market for servicing its da Vinci surgi... (more story)

Metabase, Pediatric Telehealth Biz Sued Over Patient Info Leak

Open-source AI analytics company Metabase Inc. and pediatric telehealth provider Blueberry Medical failed to protect patients' personal health information from being exposed during a cybersecurity attack, and ... (more story)

7th Circ. Rejects Removal Of Hospital Patient Privacy Suits

The Seventh Circuit on Tuesday joined a host of other appellate courts in determining healthcare providers were not "acting under" the federal government when they created patient web portals, finding actions ... (more story)

Policy & Compliance More

Mass. Hospitals Sue Lilly Over 340B Discount Data 'Extortion'

A group of Massachusetts hospitals claim drugmaker Eli Lilly & Co. unlawfully holds hostage medication discounts meant to benefit low-income patients by demanding that hospitals hand over sensitive patient cla... (more story)

CVS Says Faulty Medicare Advantage Ratings Will Cost It $2B

Insurance giant CVS Health sued the Trump administration in Georgia federal court Monday, alleging that federal quality ratings for its Medicare Advantage contracts were calculated using methods a judge reject... (more story)

Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other lega... (more story)

3 Cases To Watch In The 340B Battles

A program that determines prescription drug costs across the country is being hashed out in the courts. Here are three cases to watch that could have lasting effects on the program's future.

Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "fal... (more story)

Feds Say States Lack Standing To Sue Over HHS Vax Overhaul

The Trump administration is again asking a California federal judge to toss a coalition of states' lawsuit challenging its decision to cut vaccine recommendations for children, arguing that the states cannot s... (more story)